The 3rd New Product Planning Summit will take place December 12-13 in Boston serving as a platform for early product development, launch management, brand planning and marketing executives to address the cross-functional challenges across a product’s development cycle. This event will feature valuable insights on how to establish a framework that will allow companies to develop a value proposition for new products tailored to the needs and expectations of different stakeholders, and develop a product plan from early phase to market launch. Discover valuable strategies to guide product development from discovery through launch to ensure the successful commercialization of a new drug. Develop an effective value proposition using clinical endpoints and patient-reported outcomes that can impact communications with payers and help secure formulary placement. Gain an overview of organizational structure, functional involvement at each phase of product development, and the optimal utilization of expertise to drive alignment of new product and brand planning with unmet patient needs. Identify the commercial viability of drug candidates and opportunities for indication expansion to help prioritize and redirect funding to projects with a high potential for success. Bridge communication gaps between premarket commercialization and global marketing teams to effectively inform the product development process. URLs:Tickets: https://go.evvnt.com/268793-2?pid=5569Brochure: https://go.evvnt.com/268793-3?pid=5569Booking: https://go.evvnt.com/268793-4?pid=5569 Time: 8:00 am - 3:15 pm Prices:Early Bird Pricing: USD 1895.0,Standard Pricing: USD 2095.0,Onsite Pricing: USD 2295.0 Speakers: Tony Russel, Charles Pek, Katja Wachtendonk, Katie MacFarlane, Vincent Fisher Venue Details: Hilton Boston Back Bay, 40 Dalton Street, Boston, 02115, United States